MORRISTOWN, N.J.--(BUSINESS WIRE)--On Friday, September 20, the final Unique Device Identification (UDI) rule was issued by the Food and Drug Administration in conjunction with the 2013 UDI Conference in Baltimore, Maryland. Tom Beatty, Sr. Principal, UDI Compliance at QDevice, the medical device consulting division of QPharma, was in attendance for the announcement. “In general, industry participants at the conference seemed pleased that their feedback regarding the draft rule was heard and considered by FDA,” noted Beatty.
Help employers find you! Check out all the jobs and post your resume.
